电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant TNFRSF8 (Brentuximab Biosimilar) 抗体

This anti-TNFRSF8 (Brentuximab Biosimilar) antibody is a Human 单克隆 antibody detecting TNFRSF8 (Brentuximab Biosimilar) in ELISA, BLI, FACS, Func 和 SPR. Suitable for 人.
产品编号 ABIN7581724
发货至: 中国

Quick Overview for Recombinant TNFRSF8 (Brentuximab Biosimilar) 抗体 (ABIN7581724)

抗原

TNFRSF8 (Brentuximab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 1
  • 1
  • 1
Human

克隆类型

  • 2
  • 1
单克隆

标记

  • 3
This TNFRSF8 (Brentuximab Biosimilar) antibody is un-conjugated

应用范围

ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab)

    序列

    QIQLQQSGPE VVKPGASVKI SCKASGYTFT DYYITWVKQK PGQGLEWIGW IYPGSGNTKY NEKFKGKATL TVDTSSSTAF MQLSSLTSED TAVYFCANYG NYWFAYWGQG TQVTVSAAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPG,DIVLTQSPAS LAVSLGQRAT ISCKASQSVD FDGDSYMNWY QQKPGQPPKV LIYAASNLES GIPARFSGSG SGTDFTLNIH PVEEEDAATY YCQQSNEDPW TFGGGTKLEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC

    产品特性

    Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.38 kDa.

    纯度

    >95 %

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: CD30 inhibitors

    Conditions: Anaplastic Large Cell Lymphoma Hematologic malignancies Hodgkin Lymphoma

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    TNFRSF8 (Brentuximab Biosimilar)

    物质类

    Biosimilar

    背景

    Synonyms: TNFRSF8

    分子量

    145.38 kDa

    UniProt

    P28908
You are here:
Chat with us!